Pub. Date : 2021 Feb 26
PMID : 33637706
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Receptor tyrosine kinase (RTK) inhibitors, such as sunitinib and sorafenib, remain the first-line drugs for the treatment of mRCC. | sorafenib | ret proto-oncogene | Homo sapiens |
2 | Receptor tyrosine kinase (RTK) inhibitors, such as sunitinib and sorafenib, remain the first-line drugs for the treatment of mRCC. | sorafenib | ret proto-oncogene | Homo sapiens |